Chemoradiotherapy with weekly cisplatin 40 mg/m2 in 103 head-and-neck cancer patients : aa cumulative dose-effect analysis

Strahlentherapie und Onkologie

Volumn 185, Issue 10, 2009, Pages 682-688

  Steinmann, Diana ^a   Cerny, Bettina ^a   Karstens, Johann Hinrich ^a   Bremer, Michael ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Chemoradiotherapy; Cisplatin; Cumulative dose; Head and neck cancer

Indexed keywords

CISPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TOXICITY; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEAD AND NECK CANCER; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCYTOPENIA; RADIATION DOSE; THROMBOCYTOPENIA;

ACTUARIAL ANALYSIS; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, HIGH-ENERGY;

EID: 70349761653     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-009-1989-5     Document Type: Article

References (26)

1. D.J. Adelstein Y. Li G.L. Adams 2003 An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 92 8 12506176 10.1200/JCO.2003.01.008
2. D.J. Adelstein J.P. Saxton L.A. Rybicki 2006 Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution J Clin Oncol 24 1064 71 16505425 10.1200/JCO.2005.01.5867 1:CAS:528:DC%2BD28XislGgsb0%3D (Pubitemid 46638803)
3. M. Al-Sarraf M. LeBlanc P.G. Giri 1998 Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 J Clin Oncol 6 1310 7
4. J.M. Bachaud E. Cohen-Jonathan C. Alzieu 1996 Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial Int J Radiat Oncol Biol Phys 36 999 1004 8985019 1:CAS:528:DyaK2sXnvFynsg%3D%3D
5. G.K. Beckmann F. Hoppe L. Pfreundner 2005 Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer Head Neck 27 36 43 15459918 10.1002/hed.20111 (Pubitemid 40024087)
6. J. Bernier C. Domenge M. Ozsahin 2004 European Organization for Research and Treatment of Cancer trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 1945 52 15128894 10.1056/NEJMoa032641 1:CAS:528:DC%2BD2cXjslehsrk%3D (Pubitemid 38580197)
7. E. Bölke P.A. Gerber G. Lammering 2008 Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab Strahlenther Onkol 184 105 10 18259703 10.1007/s00066-008-1829-z (Pubitemid 351231657)
8. D. Bottke K. Bathe T. Wiegel 2007 Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck Strahlenther Onkol 183 128 32 17340070 10.1007/s00066-007-1597-1 (Pubitemid 46364895)
9. J. Bourhis A. Le Maître B. Baujat 2007 Meta-Analysis of Chemotherapy in Head, Neck Cancer Collaborative Group, Meta-Analysis of Radiotherapy in Carcinoma of Head, Neck Collaborative Group, Meta-Analysis of Chemotherapy in Nasopharynx Carcinoma Collaborative Group. Individual patients' data meta-analyses in head and neck cancer Curr Opin Oncol 19 188 94 17414635 10.1097/CCO.0b013e3280f01010 (Pubitemid 46597476)
10. G.P. Browman D.I. Hodson R.J. Mackenzie 2001 Cancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site Group. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis Head Neck 23 579 89 11400247 10.1002/hed.1081 1:STN:280: DC%2BD3MzjtFyntg%3D%3D (Pubitemid 32565532)
11. Cancer Therapy Evaluation Program. 2006 Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS March 31, 2003 National Cancer Institute Bethesda, MD, USA Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS March 31, 2003 ( http://ctep.cancer.gov ). Bethesda, MD, USA: National Cancer Institute, August 9, 2006
12. J.S. Cooper T.F. Pajak A.A. Forastiere 2004 Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 1937 44 15128893 10.1056/NEJMoa032646 (Pubitemid 38580196)
13. H.T. Eich M. Löschcke M. Scheer 2008 Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients Strahlenther Onkol 184 23 9 18188519 10.1007/s00066-008-1725-6
14. M.H. Einstein A.P. Novetsky M. Garg 2007 Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer Cancer 109 48 53 17123270 10.1002/cncr.22369 1:CAS:528:DC%2BD2sXhtVKrtb8%3D (Pubitemid 46127200)
15. A.A. Forastiere H. Goepfert M. Maor 2003 Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2091 8 14645636 10.1056/NEJMoa031317 1:CAS:528:DC%2BD3sXptlKiu7s%3D (Pubitemid 37464533)
16. J. Green J. Kirwan J. Tierney 2005 Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix Cochrane Database Syst Rev 3 CD002225 16034873
17. K.F. Ho R. Swindell C.V. Brammer 2008 Dose intensity comparison between weekly and 3-weekly cisplatin delivered concurrently with radical radiotherapy for head and neck cancer: a retrospective comparison from New Cross Hospital, Wolverhampton, UK Acta Oncol 47 1513 8 18607863 10.1080/02841860701846160 1:CAS:528:DC%2BD1cXht1ymsrnN
18. B. Jeremic B. Milicic A. Dagovic 2004 Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck J Clin Oncol 22 3540 8 15337803 10.1200/JCO.2004.10.076 (Pubitemid 41103660)
19. Kuhnt T, Sandner A, Wendt TG, et al. Concomitant hyperfractionated accelerated radiotherapy (HART) with cisplatin and concurrent cetuximab for locoregionally advanced squamous cell head and neck cancer: a phase I dose escalation trial. J Clin Oncol 2008;26:abstract 6029.
20. V.A. Marcial T.F. Pajak M. Mohiuddin 1990 Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17 Cancer 66 1861 8 2224782 10.1002/1097-0142(19901101)66:9<1861::AID- CNCR2820660902>3.0.CO;2-I 1:STN:280:DyaK3M%2FivFSrug%3D%3D
21. D.G. Pfister Y.B. Su D.H. Kraus 2006 Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm J Clin Oncol 24 1072 8 16505426 10.1200/JCO.2004.00.1792 1:CAS:528: DC%2BD28XislGgsbo%3D (Pubitemid 46638804)
22. J.P. Pignon A. le Maître J. Bourhis MACH-NC Collaborative Group 2007 Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update Int J Radiat Oncol Biol Phys 69 112 4
23. D. Rades F. Fehlauer M. Sheikh-Sarraf 2008 Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer Head Neck 30 235 41 17657790 10.1002/hed.20683 (Pubitemid 351251708)
24. D. Rades M. Stoehr T. Meyners 2008 Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer Strahlenther Onkol 184 198 205 18398584 10.1007/s00066-008-1825-3
25. M.A. Torres A. Jhingran H.D. Thames Jr 2008 Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment Int J Radiat Oncol Biol Phys 70 118 25 17869451
26. H.A. Wolff T. Overbeck R. Rödel 2008 Effektivität und Toxizität niedrig - do sierter, täglicher Cisplatin-Applikation (6 mg/m2 Körperoberfläche) bei der kombinierten Radiochemotherapie lokal fortgeschrittener Kopf-Hals-Tumore Strahlenther Onkol 184 Sondernr1 134